Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).

Clinical Journal of the American Society of Nephrology : CJASN
Linda F FriedVA NEPHRON-D Investigators

Abstract

Both angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) can slow the progression of diabetic nephropathy. Even with ACEI or ARB treatment, the proportion of patients who progress to end-stage renal disease (ESRD) remains high. Interventions that achieve more complete blockade of the renin-angiotensin system, such as combination ACEI and ARB, might be beneficial. This approach may decrease progression of nondiabetic kidney disease. In diabetic nephropathy, combination therapy decreases proteinuria, but its effect in slowing progression is unknown. In addition, the potential for hyperkalemia may limit the utility of combined therapy in this population. VA NEPHRON-D is a randomized, double-blind, multicenter clinical trial to assess the effect of combination losartan and lisinopril, compared with losartan alone, on the progression of kidney disease in 1850 patients with diabetes and overt proteinuria. The primary endpoints are time to (1) reduction in estimated GFR (eGFR) of > 50% (if baseline < 60 ml/min/1.73 m(2)); (2) reduction in eGFR of 30 ml/min/1.73 m(2) (if baseline > or = 60 ml/min/1.73 m(2)); (3) progression to ESRD (need for dialysis, renal transplant, or eGFR < 15 ml/min/1.73 m(2)...Continue Reading

Associated Clinical Trials

References

May 31, 2001·Kidney International·R Agarwal
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 22, 2001·The New England Journal of Medicine·E J Emanuel, F G Miller
Jan 5, 2002·The New England Journal of Medicine·J N CohnUNKNOWN Valsartan Heart Failure Trial Investigators
May 29, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Peter JacobsenHans-Henrik Parving
Oct 2, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Garabed EknoyanRobert Toto
Oct 9, 2003·Kidney International. Supplement·Allan J CollinsCharles A Herzog
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
Aug 6, 2004·The New England Journal of Medicine·Biff F Palmer
Jan 24, 2007·American Journal of Nephrology·Anil Bidani
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Lesley A StevensAndrew S Levey
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
May 13, 2008·Lancet·Regina KunzJohannes F E Mann

❮ Previous
Next ❯

Citations

May 22, 2010·Cardiovascular Drugs and Therapy·Christian W Mende
Jan 15, 2011·Current Atherosclerosis Reports·Gianpaolo ReboldiPaolo Verdecchia
Jun 10, 2010·Current Diabetes Reports·Raimund H Pichler, Ian H de Boer
Sep 10, 2009·Current Hypertension Reports·Radica Z AlicicKatherine R Tuttle
Sep 10, 2009·Current Hypertension Reports·Kunal ChaudharyAdam Whaley-Connell
Aug 10, 2010·Current Hypertension Reports·Giovanna LeonciniRoberto Pontremoli
Aug 13, 2010·Current Hypertension Reports·Michael R Lattanzio, Matthew R Weir
Oct 5, 2013·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Francesca ViazziRoberto Pontremoli
Oct 12, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Anastasia G PtinopoulouAnastasios N Lasaridis
Nov 12, 2013·The New England Journal of Medicine·Linda F FriedUNKNOWN VA NEPHRON-D Investigators
Sep 19, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Richard HaynesMartin J Landray
Nov 12, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marie Frimodt-MøllerAnne-Lise Kamper
Mar 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ausilia MaioneGiovanni F M Strippoli
Jan 7, 2010·Current Opinion in Nephrology and Hypertension·Maartje C J SlagmanGozewijn D Laverman
Jan 30, 2013·BMJ : British Medical Journal·Harikrishna MakaniFranz H Messerli
Jun 22, 2012·American Journal of Physiology. Renal Physiology·Dileep KumarPravin C Singhal
Oct 15, 2009·Diabetology & Metabolic Syndrome·Themis ZelmanovitzLuís H Canani
Jan 21, 2012·The Review of Diabetic Studies : RDS·Hiddo J Lambers Heerspink, Dick de Zeeuw
Feb 21, 2014·The New England Journal of Medicine·Linda F FriedJane H Zhang
May 28, 2013·Journal of Diabetes Research·Stephen P O'BrienStefan Wawersik
Dec 4, 2013·Nature Reviews. Nephrology·Sara S RoscioniDick de Zeeuw
Mar 8, 2013·American Journal of Physiology. Renal Physiology·Nirupama ChandelPravin C Singhal
Oct 30, 2009·Current Cardiology Reports·Rigas G Kalaitzidis, George L Bakris
Sep 10, 2010·Current Cardiology Reports·Sulaf J MansurSuzanne Oparil
Nov 17, 2015·Journal of Clinical Medicine·Luz Lozano-Maneiro, Adriana Puente-García
Dec 18, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Suzanne Watnick, Susan T Crowley
Jul 29, 2010·Kidney International·George L Bakris
Jul 30, 2010·Kidney International·Michael R Lattanzio, Matthew R Weir
Jul 16, 2014·Kidney International Supplements·Paul E Drawz, Mark E Rosenberg
Dec 15, 2011·Kidney International·Jeffrey M TurnerThomas H Hostetter
Jan 20, 2012·Kidney International·Adriana M HungMarie R Griffin
May 3, 2014·Kidney International·Mark E MolitchCarl E Mogensen
Jun 3, 2011·Kidney International·Michelle W KrauseSudhir V Shah
Oct 15, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Shuchi Anand, Manjula Kurella Tamura
Jul 26, 2011·Advances in Chronic Kidney Disease·Hiddo J Lambers Heerspink
Jan 25, 2011·Cardiology Clinics·Krishnaswami Vijayaraghavan, Prakash Deedwania
Jan 12, 2011·The American Journal of Medicine·Peter PeduzziGrant D Huang
Jan 13, 2011·Advances in Chronic Kidney Disease·Jerry Yee
Apr 13, 2010·Lancet·Matthew T JamesMarcello Tonelli
Dec 6, 2014·Journal of Atherosclerosis and Thrombosis·Ko HanaiYasuko Uchigata
Dec 2, 2015·Clinical Medicine : Journal of the Royal College of Physicians of London·Frank WardPatrick T Murray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
ONTARGET InvestigatorsC Anderson
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Hans-Henrik ParvingMarc A Pfeffer
© 2021 Meta ULC. All rights reserved